ACCESS TO INNOVATION AND ECONOMIC BURDEN-A CASE OF NON-SMALL CELL LUNG CANCER IN A PATIENT ACCESS PROGRAM IN QINGDAO, CHINA

被引：0
|
作者：
Chen, W. [1 ]
Lin, Y. [1 ]
Zhang, L. [1 ]
机构：
[1] Fudan Univ, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1368
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN351
引用
收藏
页码：A492 / A492
页数：1
相关论文
共 50 条
  • [1] Osimertinib in Non-Small Cell Lung Cancer: Analysis of Access Program Data in New Zealand
    Yeojeong, S.
    Fraser, A.
    Rivalland, G.
    McKeage, M.
    Sullivan, R.
    Laird, C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 73 - 74
  • [2] Access to radical treatment for patients with non-small cell lung cancer
    Eccles, A.
    Magee, N. D.
    Warke, T. J.
    LUNG CANCER, 2016, 91 : S9 - S9
  • [3] Local Experience in an Expanded Access Program of Nivolumab in Advanced Non-Small Cell Lung Cancer in Brazil
    Araujo, Luiz H.
    Baldotto, Clarissa
    Martins, Cicero
    Zukin, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1303 - S1303
  • [4] ECONOMIC BURDEN OF BRAIN METASTASES IN PATIENTS WITH ALK plus NON-SMALL CELL LUNG CANCER IN CHINA
    Xiao, F.
    Peng, X.
    Li, R.
    Luan, L.
    Le, H.
    Dong, P.
    VALUE IN HEALTH, 2024, 27 (12) : S99 - S99
  • [5] Modern Radiotherapy Increases Patient Access to Curative Intent Radiotherapy in Non-Small Cell Lung Cancer
    Tumelty, K.
    Mcaleese, J.
    Rooney, C.
    Walls, G.
    Eakin, R.
    Harney, J.
    Young, L.
    Hanna, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1009 - S1010
  • [6] Access to Biomarker Testing in Patients with Advanced Non-Small Cell Lung Cancer
    Ganti, Apar
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ramalingam, Suresh
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Borghaei, Hossein
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S964 - S965
  • [7] EGFR mutation screening in non-small cell lung cancer: Results from an access program in Brazil.
    Ponies, Luciola De Barros
    Bacchi, Carlos E.
    Queiroga, Eduardo M.
    Piha, Tony
    Miranda, Paulo Andre
    Freire, Sandra
    Lopes, Gilberto
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] A Review of Outcomes for Tasmanian Patients with Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab on the Access Program
    Conduit, C.
    Black, A.
    Grundy, R.
    Moldovan, C.
    Nott, L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 44 - 44
  • [9] Initial safety results of an expanded access program (EAP) of erlotinib in non-small cell lung cancer (NSCLC).
    Reck, M.
    Perng, R.
    Groen, H.
    Riska, H.
    Pirker, R.
    Sederholm, C.
    Caspar, C.
    Boyer, M.
    Berzinec, P.
    Allan, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 411S - 411S
  • [10] Advancements in Non-Small Cell Lung Cancer: Solving access to lung cancer care across Europe
    Brooks, Eric D.
    De Leo, Alexandra N.
    LANCET REGIONAL HEALTH-EUROPE, 2024, 38
12345